Regional impact of prophylaxis with the monoclonal antibody palivizumab on hospitalisations for respiratory syncytial virus in infants.

Source:http://linkedlifedata.com/resource/pubmed/id/11416887

Swiss Med Wkly 2001 Mar 24 131 11-12 146-51

Download in:

View as

Triples

General Info

PMID
11416887